Calverton Pharmacy Limited

POWER SEARCH PRICING

SOLUTIONS

calverton pharmacy limited Company Information

Live

EstablishedSmallHealthy

Company Number

07203442

Next Accounts

Dec 2024

Industry

Other human health activities

Directors

Mahesh Shah

Aswin Shah

View All

Shareholders

rightpharm ltd

Group Structure

View All

Contact

Registered Address

ashleigh mann 60a, station road, north harrow, HA2 7SL

Website

www.calvertonpharmacy.co.uk

calverton pharmacy limited Estimated Valuation

£4.1m

Pomanda estimates the enterprise value of CALVERTON PHARMACY LIMITED at £4.1m based on Net Assets of £1.7m and 2.46x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Calverton Pharmacy Limited is a live company located in north harrow, HA2 7SL with a Companies House number of 07203442. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2010, it's largest shareholder is rightpharm ltd with a 100% stake. Calverton Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at £1.3m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Calverton Pharmacy Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

5 Strong

3 Regular

4 Weak

Size

annual sales of £1.3m, make it larger than the average company (£715.2k)

Growth

3 year (CAGR) sales growth of 8%, show it is growing at a faster rate (5.4%)

EXPORT

Calverton Pharmacy Limited's latest turnover from March 2023 is estimated at £1.3 million and the company has net assets of £1.7 million. According to their latest financial statements, Calverton Pharmacy Limited has 8 employees and maintains cash reserves of £268.6 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Turnover	1,299,603	1,253,095	1,243,176	1,035,687	872,648	2,729,250	1,719,938	2,023,881	3,149,409	3,241,313	2,808,800
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	827,003	806,144	833,507	672,119	575,451	1,754,639	1,067,107	1,264,007	1,961,872	2,009,205	1,694,779
Gross Profit	472,600	446,951	409,669	363,569	297,197	974,611	652,831	759,874	1,187,537	1,232,108	1,114,021
Admin Expenses	299,964	156,749	312,608	242,812	185,035	962,649	489,904	631,826	1,083,188	1,066,608	997,786
Operating Profit	172,636	290,202	97,061	120,757	112,162	11,962	162,927	128,048	104,349	165,500	116,235
Interest Payable	0	0	0	0	0	18,434	37,777	22,672	5,050	3,231	0
Interest Receivable	12,070	1,295	58	87	580	240	83	101	158	266	157
Pre-Tax Profit	184,706	291,498	97,119	120,844	112,742	-6,232	125,234	105,478	99,457	162,535	116,392
Tax	-35,094	-55,385	-18,453	-22,960	-21,421	0	-25,047	-21,095	-20,886	-37,383	-27,934
Profit After Tax	149,612	236,113	78,666	97,884	91,321	-6,232	100,187	84,382	78,571	125,152	88,458
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	149,612	236,113	78,666	97,884	91,321	-6,232	100,187	84,382	78,571	125,152	88,458
Employee Costs	196,903	163,920	159,845	156,242	153,202	1,527,214	964,804	1,161,821	1,833,290	1,882,064	1,656,825
Number Of Employees	8	7	7	7	7	72	46	55	84	87	77
EBITDA*	172,636	292,063	98,865	120,890	112,295	12,139	163,163	128,362	104,768	166,059	116,533

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Tangible Assets	4,587	5,581	5,412	264	397	530	707	943	1,257	1,676	2,235
Intangible Assets	925,000	925,000	925,000	925,000	925,000	925,000	925,000	925,000	925,000	925,000	925,000
Investments & Other	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	929,587	930,581	930,412	925,264	925,397	925,530	925,707	925,943	926,257	926,676	927,235
Stock & work in progress	54,325	46,475	55,750	52,216	45,400	50,638	46,531	43,668	46,087	58,547	52,775
Trade Debtors	156,954	143,826	130,405	139,099	115,070	6,508	114,842	136,206	213,829	205,096	162,855
Group Debtors	666,779	498,886	416,770	234,079	100,864	0	0	0	0	0	0
Misc Debtors	43,763	26,545	36,353	25,827	15,444	0	80,369	79,479	0	0	0
Cash	268,646	299,358	45,998	69,812	104,703	50,089	46,029	20,688	19,769	43,504	62,762
misc current assets	0	0	0	0	0	0	0	0	0	0	0
total current assets	1,190,467	1,015,090	685,276	521,033	381,481	107,235	287,771	280,041	279,685	307,147	278,392
total assets	2,120,054	1,945,671	1,615,688	1,446,297	1,306,878	1,032,765	1,213,478	1,205,984	1,205,942	1,233,823	1,205,627
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	156,454	132,324	127,347	65,838	59,614	562,246	140,589	154,572	188,007	170,690	169,568
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	281,002	280,361	191,468	162,252	126,941	0	28,927	33,209	0	0	0
total current liabilities	437,456	412,685	318,815	228,090	186,555	562,246	169,516	187,781	188,007	170,690	169,568
loans	0	0	0	0	0	0	567,211	641,639	55,962	99,416	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	669,791	750,106	947,600
provisions	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	567,211	641,639	725,753	849,522	947,600
total liabilities	437,456	412,685	318,815	228,090	186,555	562,246	736,727	829,420	913,760	1,020,212	1,117,168
net assets	1,682,598	1,532,986	1,296,873	1,218,207	1,120,323	470,519	476,751	376,564	292,182	213,611	88,459
total shareholders funds	1,682,598	1,532,986	1,296,873	1,218,207	1,120,323	470,519	476,751	376,564	292,182	213,611	88,459

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
Operating Activities
Operating Profit	172,636	290,202	97,061	120,757	112,162	11,962	162,927	128,048	104,349	165,500	116,235	0	0
Depreciation	0	1,861	1,804	133	133	177	236	314	419	559	298	0	0
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	-35,094	-55,385	-18,453	-22,960	-21,421	0	-25,047	-21,095	-20,886	-37,383	-27,934	0	0
Stock	7,850	-9,275	3,534	6,816	-5,238	4,107	2,863	-2,419	-12,460	5,772	52,775	0	0
Debtors	198,239	85,729	184,523	167,627	224,870	-188,703	-20,474	1,856	8,733	42,241	162,855	0	0
Creditors	24,130	4,977	61,509	6,224	-502,632	421,657	-13,983	-33,435	17,317	1,122	169,568	0	0
Accruals and Deferred Income	641	88,893	29,216	35,311	126,941	-28,927	-4,282	33,209	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-43,776	254,094	-16,920	-34,978	-504,449	589,465	137,462	107,604	104,926	81,785	42,537	0	0
Investing Activities
capital expenditure	994	-2,030	-6,952	0	0	0	0	0	0	0	-927,533	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	994	-2,030	-6,952	0	0	0	0	0	0	0	-927,533	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	-567,211	-74,428	585,677	-43,454	99,416	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	-669,791	-80,315	-197,494	947,600	0	0
share issue	0	0	0	0	558,483	0	0	0	0	0	1	0	0
interest	12,070	1,295	58	87	580	-18,194	-37,694	-22,571	-4,892	-2,965	157	0	0
cash flow from financing	12,070	1,295	58	87	559,063	-585,405	-112,122	-106,685	-128,661	-101,043	947,758	0	0
cash and cash equivalents
cash	-30,712	253,360	-23,814	-34,891	54,614	4,060	25,341	919	-23,735	-19,258	62,762	0	0
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-30,712	253,360	-23,814	-34,891	54,614	4,060	25,341	919	-23,735	-19,258	62,762	0	0

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for calverton pharmacy limited. Get real-time insights into calverton pharmacy limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for calverton pharmacy limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in HA2 area or any other competitors across 12 key performance metrics.

CALVERTON PHARMACY LIMITED group structure

Calverton Pharmacy Limited has no subsidiary companies.

Ultimate parent company

RIGHTPHARM LTD

08552235

1 parent

CALVERTON PHARMACY LIMITED

07203442

CALVERTON PHARMACY LIMITED Shareholders

rightpharm ltd

100%

Calverton Pharmacy Limited currently has 3 directors. The longest serving directors include Mr Mahesh Shah (Apr 2018) and Mr Aswin Shah (Apr 2018).

officer	country	age	start	end	role
Mr Mahesh Shah		68 years	Apr 2018	-	Director
Mr Aswin Shah	England	71 years	Apr 2018	-	Director
Mr Rushab Shah	England	34 years	Dec 2021	-	Director

P&L

March 2023

turnover

1.3m

+4%

operating profit

172.6k

gross margin

36.4%

+1.95%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

1.7m

+0.1%

total assets

2.1m

+0.09%

cash

268.6k

-0.1%

net assets

Total assets minus all liabilities

Similar Companies

h & h care homes limited

herts mind network limited

exora international limited

3.5

damsbrook limited

gowrie retail ltd

company number

07203442

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

March 2010

ultimate parent company

RIGHTPHARM LTD

previous names

N/A

address

ashleigh mann 60a, station road, north harrow, HA2 7SL

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to calverton pharmacy limited. Currently there are 4 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CALVERTON PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.

calverton pharmacy limited Company Information

calverton pharmacy limited Estimated Valuation

calverton pharmacy limited Estimated Valuation

calverton pharmacy limited Estimated Valuation

Calverton Pharmacy Limited Overview

Calverton Pharmacy Limited Health Check

CALVERTON PHARMACY LIMITED financials

calverton pharmacy limited Credit Report and Business Information

Calverton Pharmacy Limited Competitor Analysis

calverton pharmacy limited Ownership

calverton pharmacy limited directors

calverton pharmacy limited company details

calverton pharmacy limited Charges & Mortgages

calverton pharmacy limited Capital Raised & Share Issues BETA

calverton pharmacy limited Companies House Filings - See Documents